US Stock MarketDetailed Quotes

MEDIF MEDIPHARM LABS CORP

Watchlist

0.068500
+0.012333+21.96%

15min DelayTrading Apr 30 15:10 ET

27.68MMarket Cap-2362P/E (TTM)

MEDIPHARM LABS CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

23.21%-12.34M

977.38%1.47M

-11.95%-3.23M

-1.59%-7.53M

45.54%-3.05M

-21.62%-16.07M

95.85%-168K

-1,088.07%-2.89M

-151.25%-7.41M

6.24%-5.6M

Net income from continuing operations

56.37%-13.08M

47.14%-2.97M

45.44%-4.33M

69.92%-2.7M

58.59%-3.09M

45.29%-29.98M

74.23%-5.61M

-7.82%-7.93M

23.92%-8.99M

46.22%-7.46M

Operating gains losses

-70.47%269K

-100.91%-10K

103.16%38K

-82.28%236K

101.58%5K

131.31%911K

540.56%1.1M

-1,680.26%-1.2M

357.73%1.33M

89.53%-317K

Depreciation and amortization

-12.40%2.52M

32.78%717K

-18.17%617K

-8.83%692K

-40.17%490K

-49.01%2.87M

-77.34%540K

-15.66%754K

-48.72%759K

-6.51%819K

Other non cash items

-1,420.70%-7.35M

-835.29%-2.23M

1,018.10%1.07M

-7,142.68%-5.94M

-421.28%-245K

-104.70%-483K

4.03%-238K

-134.94%-116K

-115.62%-82K

-100.49%-47K

Change In working capital

-44.70%3.45M

31.34%5.17M

-142.64%-1.36M

37.98%-952K

-11.08%586K

-1.83%6.24M

65.49%3.94M

-27.41%3.18M

-1,548.11%-1.54M

229.72%659K

-Change in receivables

77.74%6.42M

318.87%5.77M

-314.95%-230K

1,204.35%900K

-101.07%-22K

-64.55%3.61M

-79.71%1.38M

-97.14%107K

103.11%69K

9.94%2.06M

-Change in inventory

3,123.30%3.11M

88.96%2.23M

-122.78%-416K

104.83%106K

231.50%1.2M

-104.14%-103K

18.75%1.18M

247.50%1.83M

-146.28%-2.2M

54.77%-911K

-Change in payables and accrued expense

-446.48%-5.17M

-269.80%-1.27M

-439.27%-1.2M

-535.70%-1.9M

-1,668.89%-796K

118.39%1.49M

119.99%745K

111.83%354K

-62.93%437K

98.25%-45K

-Change in other current assets

-160.89%-1.07M

-291.93%-1.38M

-30.61%807K

-54.15%-595K

-61.24%100K

152.01%1.75M

3.30%719K

--1.16M

---386K

-88.53%258K

-Change in other current liabilities

129.13%150K

-119.28%-182K

-15.81%-315K

0.00%541K

115.12%106K

-147.12%-515K

-126.95%-83K

-282.55%-272K

-21.02%541K

-1,330.61%-701K

Cash from discontinued investing activities

Operating cash flow

23.21%-12.34M

977.38%1.47M

-11.95%-3.23M

-1.59%-7.53M

45.54%-3.05M

-21.62%-16.07M

95.85%-168K

-1,088.07%-2.89M

-151.25%-7.41M

6.24%-5.6M

Investing cash flow

Cash flow from continuing investing activities

33.23%6.87M

-24.49%4.31M

619.94%1.64M

1,187.36%946K

82.64%-25K

14,637.14%5.16M

1,937.50%5.71M

-834.88%-316K

34.09%-87K

7.69%-144K

Capital expenditure reported

45.42%-471K

61.49%-119K

17.72%-260K

28.72%-67K

82.64%-25K

-10.22%-863K

-50.00%-309K

-174.78%-316K

48.91%-94K

48.20%-144K

Net PPE purchase and sale

--178K

-24,542.86%-1.73M

--1.9M

----

--0

66.67%-7K

--0

----

Net business purchase and sale

-12.50%5.26M

-29.35%4.25M

--0

----

--6.01M

--0

----

Net other investing changes

27,085.71%1.9M

----

-98.62%7K

----

Cash from discontinued investing activities

Investing cash flow

33.23%6.87M

-24.49%4.31M

619.94%1.64M

1,187.36%946K

82.64%-25K

14,637.14%5.16M

1,937.50%5.71M

-834.88%-316K

34.09%-87K

7.69%-144K

Financing cash flow

Cash flow from continuing financing activities

-146.23%-368K

39.60%-241K

-109.09%-299K

-19.30%1.09M

-6,464.29%-919K

-97.14%796K

-40,000.00%-399K

76.17%-143K

3,855.56%1.35M

-100.05%-14K

Net issuance payments of debt

-340.20%-944K

27.32%-391K

-40.07%-388K

-21.26%1M

-1,779.03%-1.17M

113.27%393K

-564.20%-538K

-241.98%-277K

1,793.33%1.27M

97.72%-62K

Cash dividends paid

--0

Net other financing activities

95.80%840K

37.58%227K

31.82%174K

125.00%189K

420.83%250K

408.63%429K

75.53%165K

140.12%132K

115.38%84K

-15.79%48K

Cash from discontinued financing activities

Financing cash flow

-146.23%-368K

39.60%-241K

-109.09%-299K

-19.30%1.09M

-6,464.29%-919K

-97.14%796K

-40,000.00%-399K

76.17%-143K

3,855.56%1.35M

-100.05%-14K

Net cash flow

Beginning cash position

-29.21%24.15M

-33.43%12.95M

-32.97%14.74M

-28.73%20.15M

-29.21%24.15M

71.30%34.11M

-48.75%19.45M

-43.25%21.99M

-32.88%28.27M

71.30%34.11M

Current changes in cash

42.31%-5.84M

7.84%5.54M

43.57%-1.89M

10.64%-5.49M

30.64%-4M

-169.16%-10.12M

236.50%5.14M

-318.25%-3.35M

-97.15%-6.15M

-125.82%-5.76M

Effect of exchange rate changes

-319.33%-329K

-14.09%-510K

-88.12%96K

163.43%85K

--0

134.97%150K

-432.14%-447K

11,442.86%808K

47.45%-134K

20.62%-77K

End cash Position

-25.53%17.98M

-33.43%12.95M

-32.97%14.74M

-28.73%20.15M

-29.21%24.15M

-48.75%19.45M

-43.25%21.99M

-32.88%28.27M

Free cash flow

24.34%-12.81M

384.07%1.36M

-9.02%-3.49M

-1.21%-7.6M

46.47%-3.08M

-20.98%-16.93M

88.78%-477K

-794.69%-3.2M

-139.50%-7.51M

8.11%-5.75M

Currency Unit

CAD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	23.21%-12.34M	977.38%1.47M	-11.95%-3.23M	-1.59%-7.53M	45.54%-3.05M	-21.62%-16.07M	95.85%-168K	-1,088.07%-2.89M	-151.25%-7.41M	6.24%-5.6M
Net income from continuing operations	56.37%-13.08M	47.14%-2.97M	45.44%-4.33M	69.92%-2.7M	58.59%-3.09M	45.29%-29.98M	74.23%-5.61M	-7.82%-7.93M	23.92%-8.99M	46.22%-7.46M
Operating gains losses	-70.47%269K	-100.91%-10K	103.16%38K	-82.28%236K	101.58%5K	131.31%911K	540.56%1.1M	-1,680.26%-1.2M	357.73%1.33M	89.53%-317K
Depreciation and amortization	-12.40%2.52M	32.78%717K	-18.17%617K	-8.83%692K	-40.17%490K	-49.01%2.87M	-77.34%540K	-15.66%754K	-48.72%759K	-6.51%819K
Other non cash items	-1,420.70%-7.35M	-835.29%-2.23M	1,018.10%1.07M	-7,142.68%-5.94M	-421.28%-245K	-104.70%-483K	4.03%-238K	-134.94%-116K	-115.62%-82K	-100.49%-47K
Change In working capital	-44.70%3.45M	31.34%5.17M	-142.64%-1.36M	37.98%-952K	-11.08%586K	-1.83%6.24M	65.49%3.94M	-27.41%3.18M	-1,548.11%-1.54M	229.72%659K
-Change in receivables	77.74%6.42M	318.87%5.77M	-314.95%-230K	1,204.35%900K	-101.07%-22K	-64.55%3.61M	-79.71%1.38M	-97.14%107K	103.11%69K	9.94%2.06M
-Change in inventory	3,123.30%3.11M	88.96%2.23M	-122.78%-416K	104.83%106K	231.50%1.2M	-104.14%-103K	18.75%1.18M	247.50%1.83M	-146.28%-2.2M	54.77%-911K
-Change in payables and accrued expense	-446.48%-5.17M	-269.80%-1.27M	-439.27%-1.2M	-535.70%-1.9M	-1,668.89%-796K	118.39%1.49M	119.99%745K	111.83%354K	-62.93%437K	98.25%-45K
-Change in other current assets	-160.89%-1.07M	-291.93%-1.38M	-30.61%807K	-54.15%-595K	-61.24%100K	152.01%1.75M	3.30%719K	--1.16M	---386K	-88.53%258K
-Change in other current liabilities	129.13%150K	-119.28%-182K	-15.81%-315K	0.00%541K	115.12%106K	-147.12%-515K	-126.95%-83K	-282.55%-272K	-21.02%541K	-1,330.61%-701K
Cash from discontinued investing activities
Operating cash flow	23.21%-12.34M	977.38%1.47M	-11.95%-3.23M	-1.59%-7.53M	45.54%-3.05M	-21.62%-16.07M	95.85%-168K	-1,088.07%-2.89M	-151.25%-7.41M	6.24%-5.6M
Investing cash flow
Cash flow from continuing investing activities	33.23%6.87M	-24.49%4.31M	619.94%1.64M	1,187.36%946K	82.64%-25K	14,637.14%5.16M	1,937.50%5.71M	-834.88%-316K	34.09%-87K	7.69%-144K
Capital expenditure reported	45.42%-471K	61.49%-119K	17.72%-260K	28.72%-67K	82.64%-25K	-10.22%-863K	-50.00%-309K	-174.78%-316K	48.91%-94K	48.20%-144K
Net PPE purchase and sale	--178K	-24,542.86%-1.73M	--1.9M	----	----	--0	66.67%-7K	--0	----	----
Net business purchase and sale	-12.50%5.26M	-29.35%4.25M	--0	----	----	--6.01M	--6.01M	--0	----	----
Net other investing changes	27,085.71%1.9M	----	----	----	----	-98.62%7K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	33.23%6.87M	-24.49%4.31M	619.94%1.64M	1,187.36%946K	82.64%-25K	14,637.14%5.16M	1,937.50%5.71M	-834.88%-316K	34.09%-87K	7.69%-144K
Financing cash flow
Cash flow from continuing financing activities	-146.23%-368K	39.60%-241K	-109.09%-299K	-19.30%1.09M	-6,464.29%-919K	-97.14%796K	-40,000.00%-399K	76.17%-143K	3,855.56%1.35M	-100.05%-14K
Net issuance payments of debt	-340.20%-944K	27.32%-391K	-40.07%-388K	-21.26%1M	-1,779.03%-1.17M	113.27%393K	-564.20%-538K	-241.98%-277K	1,793.33%1.27M	97.72%-62K
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	95.80%840K	37.58%227K	31.82%174K	125.00%189K	420.83%250K	408.63%429K	75.53%165K	140.12%132K	115.38%84K	-15.79%48K
Cash from discontinued financing activities
Financing cash flow	-146.23%-368K	39.60%-241K	-109.09%-299K	-19.30%1.09M	-6,464.29%-919K	-97.14%796K	-40,000.00%-399K	76.17%-143K	3,855.56%1.35M	-100.05%-14K
Net cash flow
Beginning cash position	-29.21%24.15M	-33.43%12.95M	-32.97%14.74M	-28.73%20.15M	-29.21%24.15M	71.30%34.11M	-48.75%19.45M	-43.25%21.99M	-32.88%28.27M	71.30%34.11M
Current changes in cash	42.31%-5.84M	7.84%5.54M	43.57%-1.89M	10.64%-5.49M	30.64%-4M	-169.16%-10.12M	236.50%5.14M	-318.25%-3.35M	-97.15%-6.15M	-125.82%-5.76M
Effect of exchange rate changes	-319.33%-329K	-14.09%-510K	-88.12%96K	163.43%85K	--0	134.97%150K	-432.14%-447K	11,442.86%808K	47.45%-134K	20.62%-77K
End cash Position	-25.53%17.98M	-25.53%17.98M	-33.43%12.95M	-32.97%14.74M	-28.73%20.15M	-29.21%24.15M	-29.21%24.15M	-48.75%19.45M	-43.25%21.99M	-32.88%28.27M
Free cash flow	24.34%-12.81M	384.07%1.36M	-9.02%-3.49M	-1.21%-7.6M	46.47%-3.08M	-20.98%-16.93M	88.78%-477K	-794.69%-3.2M	-139.50%-7.51M	8.11%-5.75M
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall